31.08.2015
- Amgen has won US Food and Drug Administration (FDA) approval for Repatha, the second medicine in a new class of biologics recently greenlighted by the agency and claimed to reduce...
31.10.2014
- US drugmaker Bristol-Myers Squibb and Swiss fine and specialty chemicals specialist Lonza have announced a multi-year expansion of their existing biologics manufacturing agreement...
30.09.2014
- Dramatic changes to the scientific and business environments have made it impossible for pharmaceutical companies to continue operating as they have in the past. A perceived...
11.03.2014
- Catalent Pharma Solutions announced two senior appointments to further strengthen its global biologics business. Andrew Sandford joins Catalent as Vice President Business...
08.11.2013
- The World's Biologics Drug Price Problem - Drug expenses have become a significant item in household and government budgets around the world as more innovative and pricey biotech...
25.04.2013
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics...
25.10.2012
- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, announced today that it has signed a biologics contract manufacturing agreement with...
23.10.2012
- Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of a new non-executive director to Cobra...